SCHEMBL24370076

SCHEMBL24370076

c1ccc(-c2ccccc2-c2ccc(N(c3ccccc3-c3ccccc3-c3ccccc3-c3ccccc3)c3cccc4oc5ccccc5c34)cc2)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDC14B O60729 3/20 0.34
CDC14A Q9UNH5 3/20 0.34
ALOX5 P09917 1/20 0.33
TNKS O95271 2/20 0.32
CRHR1 P34998 1/20 0.32
PLA2G2A P14555 3/20 0.32
PLA2G4A P47712 3/20 0.32
PLA2G10 O15496 1/20 0.32
CYP3A4 P08684 3/20 0.31
MAOA P21397 2/20 0.31
HPGD P15428 2/20 0.31
SMN1; SMN2 Q16637 2/20 0.31
CA12 O43570 2/20 0.31
CA1 P00915 2/20 0.31
CA2 P00918 2/20 0.31
TP53 P04637 2/20 0.31
ABCB1 P08183 2/20 0.31
AR P10275 2/20 0.31
CYP1B1 Q16678 2/20 0.31
CA9 Q16790 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24370264 1.00 CDC14B (0.34) CDC14BCDC14AALOX5TNKSCRHR1
SCHEMBL24793155 0.97 BACE1 (0.33) CDC14BCDC14AALOX5TNKSCRHR1
SCHEMBL24370019 0.94 CDC14B (0.35) CDC14BCDC14AALOX5TNKSCRHR1
SCHEMBL24472339 0.94 PLA2G2A (0.35) CDC14BCDC14AALOX5TNKSCRHR1
SCHEMBL24471672 0.94 PLA2G2A (0.35) CDC14BCDC14AALOX5TNKSCRHR1
SCHEMBL24370052 0.94 CDC14B (0.35) CDC14BCDC14AALOX5TNKSCRHR1
SCHEMBL24370273 0.94 PLA2G2A (0.38) CDC14BCDC14AALOX5TNKSCRHR1
SCHEMBL24472165 0.93 PLA2G2A (0.34) CDC14BCDC14AALOX5TNKSCRHR1
SCHEMBL24370072 0.93 CDC14B (0.36) CDC14BCDC14AALOX5TNKSCRHR1
SCHEMBL22523382 0.93 ALOX5 (0.44) CDC14BCDC14AALOX5CYP3A4SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220131079-A1 LIGHT EMITTING DEVICE AND AMINE COMPOUND FOR THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2022-04-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220131079-A1 LIGHT EMITTING DEVICE AND AMINE COMPOUND FOR THE SAME MAOA, AOC1, ALDH1A2 CDC14B 3061/4885CDC14A 3095/4885ALOX5 582/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.